Calyxo (formerly Kalera Medical) has developed an innovative vacuum-assisted kidney stone retrieval device that enables rapid and complete removal of stone fragments. The device allows procedures that are faster and easier compared to the current standard of care.
Presently, stone removal is the most unpredictable, difficult part of ureteroscopy because current tools, i.e. baskets, have serious limitations.
Kidney stones affect about 10% of the population in industrialized countries and the number is growing. There is a 50% recurrence rate within five years. Calyxo’s instrument addresses a clear unmet medical need in a rapidly growing market segment.
Presently, stone removal is the most unpredictable, difficult part of ureteroscopy because current tools, i.e. baskets, have serious limitations.
Kidney stones affect about 10% of the population in industrialized countries and the number is growing. There is a 50% recurrence rate within five years. Calyxo’s instrument addresses a clear unmet medical need in a rapidly growing market segment.
Location: United States, California, Pleasanton
Employees: 11-50
Total raised: $82.8M
Founded date: 2016
Investors 4
| Date | Name | Website |
| 06.02.2022 | CRG | crglp.com |
| - | Warren Poi... | warrenpoin... |
| - | VIC Techno... | victech.co... |
| - | Questa Cap... | questacapi... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 13.12.2023 | Series D | $50M | - |
| 06.07.2022 | Series C | $32.8M | - |
Mentions in press and media 8
| Date | Title | Description |
| 05.01.2026 | Aspiration System Correction: Calyxo Updates Use Instructions for CVAC Aspiration Systems | This recall involves updating instructions for using certain devices, and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or ... |
| 20.03.2025 | Early Alert: Aspiration System Issue from Calyxo | This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as signifi... |
| 13.12.2023 | Calyxo closes $50M funding round to support kidney stone treatment | Calyxo announced that it closed a $50 million Series D financing round to support its CVAC aspiration system for kidney stone removal. Avidity Partners led the round, with existing investors Questa Capital and CRG providing significant part... |
| 12.12.2023 | Calyxo Raises $50M in Series D Funding | Calyxo, a Pleasanton, CA-based medical device company developing next-generation treatment solutions for patients with kidney stones, raised $50M in Series D funding. The round was led by Avidity Partners with participation from existing in... |
| 12.12.2023 | Calyxo Secures $50M Series D Funding | PLEASANTON, CA, Calyxo has announced the closing of a $50 million Series D financing round. >> Click here for more funding data on Calyxo >> To export Calyxo funding data to PDF and Excel, click here Calyxo, a medical dev... |
| 07.07.2022 | Calyxo Inks $32.8M Series C Financing Round | PLEASANTON, CA, Kidney stone removal technology developer Calyxo announced that it has closed a $32.7 million Series C financing round. >> Click here for more funding data on Calyxo >> To export Calyxo funding data to PDF an... |
| 06.07.2022 | Calyxo raises $32.7M for kidney stone treatment | Kidney stone removal technology developer Calyxo announced today that it closed a $32.7 million Series C financing round. Pleasanton, California–based Calyxo develops the CVAC Aspiration system designed to use irrigation and aspiration to r... |
| - | Calyxo | “Calyxo, Inc. develops and markets innovative technology for ureteroscopic kidney stone treatment.” |